RAF1 and breast cancer: We have demonstrated that overexpression of a constitutive active Raf-1 mutant in ERa+ MCF-7 breast cancer cells (vMCF-7∆Raf1) resulted in constitutive activation of MAPK oncogenic signaling and enhanced tumorigenic properties in vivo [26, 30].